e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Biomarkers of allergic inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differences in responsiveness of blood neutrophils for fMLF indentify two distinct groups of COPD patients
V. Kamp, A. Lo Tam Loi, N. ten Hacken, S. Hoornhorst, J. W. Lammers, L. Koenderman (Utrecht, Groningen, Netherlands)
Source:
Annual Congress 2011 - Biomarkers of allergic inflammation
Session:
Biomarkers of allergic inflammation
Session type:
Poster Discussion
Number:
469
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Kamp, A. Lo Tam Loi, N. ten Hacken, S. Hoornhorst, J. W. Lammers, L. Koenderman (Utrecht, Groningen, Netherlands). Differences in responsiveness of blood neutrophils for fMLF indentify two distinct groups of COPD patients. Eur Respir J 2011; 38: Suppl. 55, 469
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Eosinophils and different clusters in COPD patients.
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Differential response of monocyte-derived macrophages from COPD and healthy subjects to LPS/IFN? stimulation
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Different expression of pro- and antiinflammatory cytokines in
chlamydia pneumoniae
infected blood monocytes and alveolar macrophages from COPD patients and healthy volunteers
Source: Eur Respir J 2002; 20: Suppl. 38, 220s
Year: 2002
The comparison of subsets of blood lymphocytes in patients with lung cancer,COPD,and tuberculosis according to healthy controls
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001
Characterization of lymphocyte subsets in the lungs of smokers and patients with COPD
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
Associations between blood eosinophils and decline in lung function among adults with and without asthma
Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017
Year: 2018
Blood eosinophil counts in COPD patients compared to controls
Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019
Year: 2019
Studies on blood lymphocytes apoptosis in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Associations of blood cytokines and eosinophils in severe asthma
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Novel sub-classifications of mast cells in human lungs: differential alterations in smokers and COPD
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007
Cytogenetic analysis in peripheral blood lymphocytes from asthmatic patients with different severity
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept